Tirzepatide × Peptira - Lab Test, November 2025
Test results
About this test
This independent HPLC lab test confirms Tirzepatide 50mg from Peptira at 99.827 purity. The analysis was conducted using HPLC with UV detection coupled with mass spectrometry on November 30, 2025.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. A purity level of 99.827 indicates high-grade synthesis with minimal impurities. Endotoxin testing passed with levels below 0.05 EU/mL, demonstrating safety standards for research use. The product appearance is a white lyophilized powder.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.